Michael Kiffe
Impact in
-
- Cancer Treatment and Pharmacology
-
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
Papers in
-
- Protein Degradation and Inhibitors 4
- Metabolomics and Mass Spectrometry Studies 3
- Cancer-related gene regulation 2
-
- Synthetic Organic Chemistry Methods 5
- Co-authors
- Gerhard Höfle (7 shared papers)Michael Sefkow (2 shared papers)Peter Christen (1 shared paper)P. Arni (1 shared paper)Andreas Weiss (3 shared papers)Eva Altmann (1 shared paper)Anita Schlierf (1 shared paper)R. Assenberg (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Rapid Communications in Mass Spectrometry (2 papers)ACS Medicinal Chemistry Letters (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Nature Communications (1 paper)
- Partner nations
- SwitzerlandGermanyChina
In The Last Decade
Michael Kiffe
21 papers receiving 456 citations
Peers
Comparison fields: 5 of 72
- Oncology 161
- Molecular Biology 272
- Organic Chemistry 99
- Cell Biology 54
- Cancer Research 43
Countries citing papers authored by Michael Kiffe
This map shows the geographic impact of Michael Kiffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kiffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kiffe more than expected).
Fields of papers citing papers by Michael Kiffe
This network shows the impact of papers produced by Michael Kiffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kiffe. The network helps show where Michael Kiffe may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Kiffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 128 | |
| 2 | 2016 | 52 | |
| 3 | 1999 | 37 | |
| 4 | 2002 | 35 | |
| 5 | 2003 | 34 | |
| 6 | 2019 | 28 | |
| 7 | 1998 | 23 | |
| 8 | 1998 | 21 | |
| 9 | 2003 | 16 | |
| 10 | 2019 | 15 | |
| 11 | 2007 | 11 | |
| 12 | 2007 | 11 | |
| 13 | 2008 | 10 | |
| 14 | 1999 | 9 | |
| 15 | 1997 | 8 | |
| 16 | 1997 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2007 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2012 | 4 |
About Michael Kiffe
Michael Kiffe is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Spectroscopy and Pharmacology, having authored 23 papers that have together received 466 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Analytical Chemistry and Chromatography (6 papers), Synthetic Organic Chemistry Methods (5 papers), Protein Degradation and Inhibitors (4 papers), Mass Spectrometry Techniques and Applications (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Analytical chemistry methods development (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Oncology (161 citations), Molecular Biology (272 citations), Organic Chemistry (99 citations), Cell Biology (54 citations) and Cancer Research (43 citations). Michael Kiffe has collaborated with scholars based in Switzerland, Germany and China. Frequent co-authors include Gerhard Höfle, Michael Sefkow, Peter Christen, P. Arni, Andreas Weiss, Eva Altmann, Anita Schlierf, R. Assenberg, Markus Trunzer and Bruno Martoglio. Their work appears in journals such as Journal of Medicinal Chemistry, Rapid Communications in Mass Spectrometry, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry Letters and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.